NON-FATAL in Croatian translation

• nefatalni
• bez smrtnog ishoda
• ne-fatalna
• nesmrtonosnog
• nefatalnog
• nefatalna

Examples of using Non-fatal in English and their translations into Croatian

Fenofibrate plus simvastatin therapy did not show any significant differences compared to simvastatin monotherapy in the composite primary outcome of non-fatal myocardial infarction, non-fatal stroke, and cardiovascular death hazard ratio[HR]
Terapija fenofibrat plus simvastatin nije pokazala bilo kakve značajne razlike u usporedbi s monoterapijom simvastatinom u smislu primarnog složenog ishoda, koji je obuhvaćao nefatalni infarkt miokarda, nefatalni moždani udar i kardiovaskularnu smrt omjer rizika[HR]

which was a composite of all-cause mortality, non-fatal myocardial infarction,
od mortaliteta svih uzroka, infarkta miokarda bez smrtnog ishoda, moždanog udara,

No statistically significant difference in the incidence of the primary composite endpoint(cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, or hospitalization for congestive heart failure)
Nije pronađena statistički značajna razlika u incidenciji primarnog kompozitnog ishoda(kardiovaskularna smrt, nefatalni infarkt miokarda, nefatalni moždani udar

In the All ACS population, prasugrel was associated with a lower incidence of CV death, non-fatal MI, or non-fatal stroke compared to clopidogrel, regardless of baseline characteristics such as age, sex, body weight,
U populaciji svih bolesnika s ACS-om primjena prasugrela je u usporedbi s primjenom klopidogrela bila povezana s nižom incidencijom smrti zbog KV uzroka, nesmrtonosnog IM odnosno nesmrtonosnog moždanog udara,

Telmisartan was found to be similarly effective to ramipril in the pre-specified secondary endpoint of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke[0.99(97.5% CI 0.90- 1.08),
Pokazalo se da je telmisartan slično učinkovit kao i ramipril u prethodno određenom sekundarnom ishodu uključujući kardiovaskularnu smrt, nefatalni infarkt miokarda i nefatalni moždani udar[0, 99(97,

had a small but significant increase in the combined risk of cardiovascular death or non-fatal heart attack with Corlentor compared with placebo 3.4% vs 2.9% yearly incidence rates.
značajno povećanje kombiniranog rizika od kardiovaskularne smrti ili nesmrtonosnog srčanog udara u usporedbi Corlentora s placebom 3,4%, odnosno 2,9% u stopi pojave bolesti godišnje.

regarding its primary endpoint, which was a composite of all-cause mortality, non-fatal myocardial infarction,
koja je bila kompozitna mjera sastavljena od mortaliteta svih uzroka; ne-fatalnog infarkta miokarda,

As for the secondary endpoint of fatal and non-fatal cardiovascular events, there was no
Za sekundarnu mjeru ishoda ispitivanja, fatalne i nefatalne kardiovaskularne događaje,

The hazard ratio for the composite primary endpoint(time to event of cardiovascular death, non-fatal stroke, non-fatal myocardial infarction,
Omjer rizika za mještoviti primarni ishod(vrijeme do događaja kardiovaskularne smrti, ne-smrtonosnog moždanog udara, ne-smrtonosnog infarkta miokarda

a composite of all VTE/all cause death, and in the Major VTE endpoint, a composite of proximal DVT, non-fatal PE, and VTE-related death, compared to enoxaparin
redukciji glavnog VTE ishoda(kombinacija proksimalne duboke venske tromboze(DVT), nesmrtonosne plućne embolije(PE) i smrtnog ishoda povezanog s venskom tromboembolijom)

Non-fatal. There's five of us.
Nije fatalan.-Nas je petero.

Fatal and non-fatal haemorrhagic and necrotizing pancreatitis*,†.
Hemoragijski i nekrotizirajući pankreatitis sa ili bez smrtnog ishoda.

Non-fatal wounds to the shoulder and knee.
Nema fatalnih rana na ramenima i koljenima.

The trial did not look at fatal and non-fatal cardiovascular endpoints as it was small and short term.
Ispitivanje nije promatralo smrtonosne i ne-smrtonosne kardiovaskularne ishode budući je bilo malo i kratko trajalo.

The primary efficacy outcome was symptomatic recurrent VTE defined as the composite of recurrent DVT or fatal or non-fatal PE.
Primarni ishod djelotvornosti bio je simptomatski ponavljajući VTE definiran kao spoj ponavljajućeg DVT-a ili smrtonosne ili nesmrtonosne plućne embolije.

The main measure of effectiveness was a reduction in the risk of death due to heart problems and non-fatal heart attack.
Glavna mjera djelotvornosti bilo je smanjenje u rizikiu od smrti uslijed srčanih problema i srčanog zastoja bez smrtonosnog ishoda.

recurrence of symptomatic VTE, defined as the composite of recurrent symptomatic DVT, non-fatal symptomatic PE and fatal PE in subjects during the 12-month study period.
kompozitna mjera sastavljena od recidivirajućeg simptomatskog DVT-a, simptomatskog PE-a bez smrtnog ishoda i PE-a sa smrtnim ishodom u ispitanika tijekom 12-mjesečnog razdoblja ispitivanja.

The fourth study showed no evidence of a higher risk of fatal and non-fatal self- harm(HR of 0.88;
U četvrtom ispitivanju nisu utvrđeni dokazi većeg rizika od samoozljeđivanja sa smrtnim ishodom ili bez njega(HR od 0,88;

Fatal and non-fatal intracranial haemorrhage(ICH)
Fatalno i nefatalno intrakranijalno krvarenje(ICH)

non-fatal stroke, non-fatal SEE, and death due to CV cause
moždanog udara bez smrtnog ishoda, SED-a bez smrtnog ishoda i smrti zbog KV uzroka